
About Regalia Pharmaceutical (India) Private Limited
Data last updated:
Regalia Pharmaceutical (India) Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2007PTC130885. Its GSTIN is 27AADCR8274P1ZJ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.69 Lakh. It is led by directors Rohit Dinanath Karpe and Anil Popatrao Belkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2024, the company reported a revenue of ₹98.56 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Lakh (net margin -1.3%) and EBITDA of ₹2.72 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 32% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website regaliapharma.com.
Company details
Contact details
Regalia Pharmaceutical (India) Private Limited's registered office is in Pune, Maharashtra. Its website is regaliapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressLower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Regalia Pharmaceutical (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Regalia Pharmaceutical (India) is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Regalia Pharmaceutical (India) Private Limited, buy the company report.
Financials of Regalia Pharmaceutical (India) Private Limited
FY 2024 filings availableRegalia Pharmaceutical (India) Private Limited reported revenue of ₹98.56 Lakh (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 15% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | -1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Regalia Pharmaceutical (India) Private Limited, buy the company report.
Board of directors of Regalia Pharmaceutical (India) Private Limited
Regalia Pharmaceutical (India) has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Dinanath Karpe Also directs: R. K. Hospi-Mediservices LLP, SPL Infusion Private Limited, Rohit-Pharma Distributors Private Limited and 4 more | Director | 20 Oct 2007 | 19 Years 0 Months | Current |
| Anil Popatrao Belkar Also directs: R. K. Hospi-Mediservices LLP, Jsu Pharmaceutical Private Limited, Wellmend Pharmaceutical Private Limited and 2 more | Director | 31 Mar 2023 | 3 Years 7 Months | Current |
Auditor
Regalia Pharmaceutical (India) Private Limited is audited by ABHAY & RAHUL for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY & RAHUL | FY 2022 | 129965W |
Shareholding
The shareholding of Regalia Pharmaceutical (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Regalia Pharmaceutical (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2016 | 100038767 | Indian Bank | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Regalia Pharmaceutical (India) Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Criminal case | Filed against the company by Pure and Cure Pvt Ltd | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Merck Sharp & Dohme Corp & Anr | Disposed |
To see the full case history of Regalia Pharmaceutical (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Regalia Pharmaceutical (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Regalia Pharmaceutical (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCR8274P1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Regalia Pharmaceutical (India) Private Limited, buy the company report.
Recent activity
Regalia Pharmaceutical (India) Private Limited has 14 board changes on record since 2007: 8 appointments and 6 cessations. The latest: Anil Popatrao Belkar was appointed as Director on 31 Mar 2023.
6 earlier events are in the company report.
Frequently asked questions
Regalia Pharmaceutical (India) is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 October 2007 (19+ years old) and is registered under CIN U24232PN2007PTC130885.
Regalia Pharmaceutical (India) has 2 current directors:
- Rohit Dinanath Karpe - Director
- Anil Popatrao Belkar - Director
The latest financial statements of Regalia Pharmaceutical (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Regalia Pharmaceutical (India) is 27AADCR8274P1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Regalia Pharmaceutical (India) is U24232PN2007PTC130885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Regalia Pharmaceutical (India) has 2 court cases on record: 2 filed against it. Most are in the district courts.
Regalia Pharmaceutical (India) was incorporated on 20 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Pune.
Anil Popatrao Belkar was appointed as Director on 31 Mar 2023. Hitesh Popatlal Oswal ceased to be Director on 31 Mar 2023. Satish Shankarrao Gadewar ceased to be Director on 31 Mar 2023. Regalia Pharmaceutical (India) has 14 board changes on record in total.
Regalia Pharmaceutical (India) can be reached through the website regaliapharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Regalia Pharmaceutical (India) is at Lower Ground Floor 112 Akruti Sankul S N 20112059 Sadashiv Peth, Pune, Maharashtra, India – 411030.

